Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Treace Medical Concepts (TMCI) Other Working Capital Changes (2020 - 2025)

Treace Medical Concepts' Other Working Capital Changes history spans 6 years, with the latest figure at -$825000.0 for Q4 2025.

  • For Q4 2025, Other Working Capital Changes rose 64.53% year-over-year to -$825000.0; the TTM value through Dec 2025 reached -$3.2 million, down 29.68%, while the annual FY2025 figure was -$3.2 million, 29.68% down from the prior year.
  • Other Working Capital Changes reached -$825000.0 in Q4 2025 per TMCI's latest filing, roughly flat from -$829000.0 in the prior quarter.
  • In the past five years, Other Working Capital Changes ranged from a high of $3.2 million in Q3 2021 to a low of -$2.3 million in Q4 2024.
  • Average Other Working Capital Changes over 5 years is -$114055.6, with a median of -$429000.0 recorded in 2021.
  • Peak YoY movement for Other Working Capital Changes: surged 902.53% in 2021, then plummeted 8947.37% in 2023.
  • A 5-year view of Other Working Capital Changes shows it stood at -$751000.0 in 2021, then plummeted by 40.88% to -$1.1 million in 2022, then skyrocketed by 218.15% to $1.2 million in 2023, then tumbled by 286.08% to -$2.3 million in 2024, then soared by 64.53% to -$825000.0 in 2025.
  • Per Business Quant, the three most recent readings for TMCI's Other Working Capital Changes are -$825000.0 (Q4 2025), -$829000.0 (Q3 2025), and -$768000.0 (Q2 2025).